Average Co-Inventor Count = 7.26
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (14 from 4,945 patents)
2. Roche Glycart Ag (3 from 68 patents)
3. F. Hoffmann-la Roche Ag (168 patents)
17 patents:
1. 11993642 - Trivalent, bispecific antibodies
2. 11787873 - Bispecific HER2 antibodies and methods of use
3. 11673945 - Bispecific antigen binding proteins
4. 11242390 - Protease-activated T cell bispecific molecules
5. 10640555 - Bispecific antigen binding proteins
6. 10584178 - Bispecific HER2 antibodies and methods of use
7. 10106600 - Bispecific antibodies
8. 9890204 - Trivalent, bispecific antibodies
9. 9879095 - Bispecific antibodies comprising a disulfide stabilized-Fv fragment
10. 9708396 - Bispecific anti-VEGF/anti-ANG-2 antibodies
11. 9676845 - Bispecific antigen binding proteins
12. 9650442 - Bispecific anti-EGFR/anti IGF-1R antibodies
13. 9382323 - Multispecific antibodies comprising full length antibodies and single chain fab fragments
14. 8796424 - Tri- or tetraspecific antibodies
15. 8703130 - Bispecific anti-VEGF/anti-ANG-2 antibodies